1. Scrip

SCM Lifescience CEO On Developing High Purity, Disease-Specific Stem Cell Therapies

 
• By Jung Won Shin

Emerging Company Profile: Capitalizing on its proprietary platform technologies designed to develop high efficacy, disease-specific and low cost stem cell products, South Korea's SCM Lifescience aims to prove in clinical trials how its product candidates differ from existing stem cell therapies.

Emerging Company Profile Regular column feature image Version 2

When CKD Pharm Vice Chairman BG Rhee left the pharma firm and became CEO of SCM Lifescience in May, people were curious to know what had drawn him to the stem cell therapy company.

"First of all, Korea has a relative strength in regenerative medicine. And SCM’s differentiated, specialized technology stood out among regenerative...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Start-Ups & SMEs

More from Business